Raposas, Jerald L.

HRN: 22-45-32  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/16/2023
01/18/2023
IV
600mg
Q6hrs
Fracture Open III B, M/3rd, Femur, Left
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: